Cargando…

Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells

Programmed cell death ligand 1 (PD‐L1) is a negative regulator of the immune response that enables tumor cells to escape T‐cell immunity. Although PD‐L1 expression in cancer cells has been extensively studied, the expression of PD‐L1 in stromal cells and its clinical significance remain largely unkn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Mengqi, Liu, Panpan, Wang, Kefeng, Glorieux, Christophe, Hu, Yumin, Wen, Shijun, Jiang, Wenqi, Huang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527486/ https://www.ncbi.nlm.nih.gov/pubmed/28218497 http://dx.doi.org/10.1002/1878-0261.12032

Ejemplares similares

Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy
por: Zhang, Panpan, et al.
Publicado: (2016)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
por: Pinato, David J., et al.
Publicado: (2017)

Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
por: Zhang, Yan, et al.
Publicado: (2011)

Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
por: Gao, Yuan, et al.
Publicado: (2017)

Mesenchymal Stromal Cell Secretion of Programmed Death‐1 Ligands Regulates T Cell Mediated Immunosuppression
por: Davies, Lindsay C., et al.
Publicado: (2016)

COX-2 upregulation by tumour cells post-chemotherapy fuels the immune evasive dark side of cancer inflammation
por: Bell, Charlotte R., et al.
Publicado: (2022)

Ghrelin Upregulates Hoxb4 Gene Expression in Rat Bone Marrow Stromal Cells
por: Abdanipour, Alireza, et al.
Publicado: (2018)

Upregulation of Fas Ligand by Simian Immunodeficiency Virus—A nef-arious Mechanism of Immune Evasion?
por: Johnson, R. Paul
Publicado: (1997)

Upregulation of Myc promotes the evasion of NK cell-mediated immunity through suppression of NKG2D ligands in K562 cells
por: Lee, Young-Shin, et al.
Publicado: (2019)

Cancer Metabolism and the Evasion of Apoptotic Cell Death
por: Sharma, Aditi, et al.
Publicado: (2019)

Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma
por: Wang, Lei, et al.
Publicado: (2016)

Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome
por: Hong, Mineui, et al.
Publicado: (2020)

Comparing the immunosuppressive potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells
por: Dao, Mo A, et al.
Publicado: (2011)

Comparing the angiogenic potency of naïve marrow stromal cells and Notch-transfected marrow stromal cells
por: Dao, Mo, et al.
Publicado: (2013)

Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer
por: Yamashita, Kohei, et al.
Publicado: (2020)

Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials
por: Zeng, Linyan, et al.
Publicado: (2022)

Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1 surface expression
por: LU, WANLU, et al.
Publicado: (2013)

Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
por: Jang, Yong Soo, et al.
Publicado: (2023)

CD4(+) T cell-induced inflammatory cell death controls immune-evasive tumours
por: Kruse, Bastian, et al.
Publicado: (2023)

Secreted Factors from Bone Marrow Stromal Cells Upregulate IL-10 and Reverse Acute Kidney Injury
por: Milwid, Jack M., et al.
Publicado: (2012)

Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Trials
por: Li, Zaishang, et al.
Publicado: (2021)

Programmed Cell Death Ligand 1-Transfected Mouse Bone Marrow Mesenchymal Stem Cells as Targeted Therapy for Rheumatoid Arthritis
por: Hu, Qiong-ying, et al.
Publicado: (2021)

Senescent cells re‐engineered to express soluble programmed death receptor‐1 for inhibiting programmed death receptor‐1/programmed death ligand‐1 as a vaccination approach against breast cancer
por: Chen, Zehong, et al.
Publicado: (2018)

Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro
por: Guo, Qiuchen, et al.
Publicado: (2022)

Level of macroautophagy drives senescent keratinocytes into cell death or neoplastic evasion
por: Deruy, E, et al.
Publicado: (2014)

Transplantation with Bone Marrow Stromal Cells Promotes Wound Healing Under Chemotherapy through Altering Phenotypes
por: Hu, Gang, et al.
Publicado: (2011)

Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation
por: de Oliveira, Felipe Leite, et al.
Publicado: (2018)

Bone Marrow Stromal Cells Derived MCP-1 Reverses the Inhibitory Effects of Multiple Myeloma Cells on Osteoclastogenesis by Upregulating the RANK Expression
por: Liu, Zhiqiang, et al.
Publicado: (2013)

Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
por: Takahashi, Hideyuki, et al.
Publicado: (2021)

Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153
por: Baban, Babak, et al.
Publicado: (2015)

Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
por: Banerjee, Debasree, et al.
Publicado: (2018)

Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
por: Jaafar, Jaafar, et al.
Publicado: (2018)

Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiation
por: Feng, Hao, et al.
Publicado: (2018)

Femur bone marrow from brain death deceased donors as source of human mesenchymal stromal cells for cell therapy
por: Echarte, Lourdes, et al.
Publicado: (2023)

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response
por: Luo, Min, et al.
Publicado: (2016)

Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis
por: Martinaud, Christophe, et al.
Publicado: (2015)

Human IgA-Expressing Bone Marrow Plasma Cells Characteristically Upregulate Programmed Cell Death Protein-1 Upon B Cell Receptor Stimulation
por: Wiedemann, Annika, et al.
Publicado: (2021)

Impact of coadministration of apigenin and bone marrow stromal cells on damaged ovaries due to chemotherapy in rat: An experimental study
por: Talebi, Athar, et al.
Publicado: (2020)

Toward Marrow Adipocytes: Adipogenic Trajectory of the Bone Marrow Stromal Cell Lineage
por: Matsushita, Yuki, et al.
Publicado: (2022)

Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
por: Sheng, Jin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7q0okpr8dprq82fnleqpv4m6l3